About
The Journal "Obstetrics and Gynecology"Journal HistoryAims and ScopePolicies on Conflict of Interest, Human and Animal Rights, and Informed ConsentEditorial ProcessData sharing statementAdvertising PolicyThe Process for Handling Cases Requiring Corrections, Retractions, and Editorial Expressions of ConcernEditorial BoardEditorial CounsilInformation for ProfessionalsNewsContacts
ArchiveEthical StandardsSubscription
For authors
InstructionsInformed consent policyContract offerEASE GuidelinesICJME CriteriaWAME Recommendations on ChatGPT and Chatbots in Relation to Scholarly Publications
Reviewing
Procedure for reviewingReviewers 2023-2024
ISSN 0300-9092 (Print)
ISSN 2412-5679 (Online)
About
The Journal "Obstetrics and Gynecology"Journal HistoryAims and ScopePolicies on Conflict of Interest, Human and Animal Rights, and Informed ConsentEditorial ProcessData sharing statementAdvertising PolicyThe Process for Handling Cases Requiring Corrections, Retractions, and Editorial Expressions of ConcernEditorial BoardEditorial CounsilInformation for ProfessionalsNewsContacts
ArchiveEthical StandardsSubscription
For authors
InstructionsInformed consent policyContract offerEASE GuidelinesICJME CriteriaWAME Recommendations on ChatGPT and Chatbots in Relation to Scholarly Publications
Reviewing
Procedure for reviewingReviewers 2023-2024
Logout
Obstetrics and Gynegology2026№3

Current issues of surgical organ-preserving treatment of uterine fibroids

DOI
https://dx.doi.org/10.18565/aig.2025.305

Loginova E.A., Ivanova L.B., Valiev R.K.

Loginov Moscow Clinical Scientific Center, Moscow Healthcare Department, Moscow, Russia

Uterine fibroids are a common benign disease of the female reproductive system. The issue of choosing the best treatment for uterine fibroids is important for young women who plan to have children. Plastic and reconstructive minimally invasive organ-preserving uterine surgery, namely laparoscopic robot-assisted myomectomy, is currently the gold standard in the treatment of reproductive-aged patients. Despite the great interest in this topic, there are still a number of significant challenges that even experienced highly qualified gynecological surgeons may face. These issues include excessive intraoperative blood loss, the need for blood transfusion, prolonged postoperative rehabilitation, the risk of diagnosing extremely malignant and aggressive uterine tumors (sarcomas), and long-term complications associated with abdominal morcellomas. This article analyzes current literature data on minimizing blood loss and potential risks of minimally invasive extraction of drugs from the abdominal cavity (morcellation) during removal of myomatous nodes using laparoscopic robot-assisted techniques.
Conclusion: A review of the available literature suggests that, despite the numerous publications, there are still areas in minimally invasive gynecologic surgery that require further study. Strategies aimed at reducing intraoperative blood loss during myomectomies and ablastic morcellation can improve the quality of surgical care for young reproductive-aged patients with uterine fibroids.

Authors’ contributions: Loginova E.A., Ivanova L.B. – developing the concept and design of the study, collecting and processing the material, writing and presenting the text; Valiev R.K., Ivanova L.B. – editing the article.
Conflicts of interest: The authors declare that there are no conflicts of interest.
Funding: The study was conducted without sponsorship.
For citation: Loginova E.A., Ivanova L.B., Valiev R.K. Current issues of 
surgical organ-preserving treatment of uterine fibroids.
Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2026; (3): 156-162 (in Russian)
https://dx.doi.org/10.18565/aig.2025.305

Keywords

uterine fibroids
laparoscopic myomectomy
robot-assisted myomectomy
bleeding
uterine artery embolization
Full text (in Russian)

References

  1. Министерство здравоохранения Российской Федерации. Клинические рекомендации. Миома матки. 2024. [Ministry of Health of the Russian Federation. Clinical guidelines. Uterine fibroids. 2024 (in Russian)].
  2. Giannini A., Cuccu I., Golia D'Auge T., De Angelis E., Laganà A.S., Chiantera V. et al. The great debate: Surgical outcomes of laparoscopic versus laparotomic myomectomy. A meta-analysis to critically evaluate current evidence and look over the horizon. Eur. J. Obstet. Gynecol. Reprod. Biol. 2024: 297: 50-8. https://dx.doi.org/10.1016/j.ejogrb.2024.03.045
  3. Sheng Y., Hong Z., Wang J., Mao B., Wu Z., Gou Y. et al. Efficacy and safety of robot-assisted laparoscopic myomectomy versus laparoscopic myomectomy: a systematic evaluation and meta-analysis. World J. Surg. Oncol. 2023; 21(1): 230. https://dx.doi.org/10.1186/s12957-023-03104-8
  4. Ciarmela P., Delli Carpini G., Greco S., Zannotti A., Montik N., Giannella L. et al. Uterine fibroid vascularization: from morphological evidence to clinical implications. Reprod. Biomed. Online. 2022; 44(2): 281-94. https://dx.doi.org/10.1016/j.rbmo.2021.09.005
  5. Frijlingh M., Stoelinga B., de Leeuw R.A., Hehenkamp W.J.K., Twisk J.W.R., van den Bosch T. et al. Microvascular flow imaging of fibroids: A prospective pilot study. Acta Obstet. Gynecol. Scand. 2024; 103(11): 2193-202. https://dx.doi.org/10.1111/aogs.14914
  6. Политова А.К., Боломатов Н.В., Бруслик С.В. Слабожанкина Е.А., Свиридова Т.И., Амелина Ю.Л. Суперселективная эмболизация артерий, питающих миоматозные узлы, при лечении пациенток с миомой матки. Вестник Национального медико-хирургического центра им. Н.И. Пирогова. 2022; 17(1): 23-27. [Politova A.K., Bolomatov N.V., Bruslik S.V., Slabozhankina E.A., Sviridova T.I., Amelina Yu.L. Superselective embolization of arteries feeding myomatous nodes in the treatment of uterine fibroids. Bulletin of the Pirogov National Medical and Surgical Center. 2022; 17(1): 23-27 (in Russian)]. https://dx.doi.org/10.25881/20728255_2022_17_1_23
  7. Slotman D.J., Frijlingh M., Juffermans L.J.M., Bartels L.W., Moonen C.T.W., Bosch van den T. et al. Understanding different aspects of blood supply of uterine fibroids: an overview of ultrasound and magnetic resonance imaging techniques. Insights Imaging. 2025; 16(1): 192. https://dx.doi.org/10.1186/s13244-025-02033-2
  8. Sleiman Z., Baba R.E., Garzon S., Khazaka A. The significant risk factors of intra-operative hemorrhage during laparoscopic myomectomy: a systematic review. Gynecol. Minim. Invasive Ther. 2019; 9(1): 6-12. https://dx.doi.org/10.4103/GMIT.GMIT_21_19
  9. Adesina K.T., Owolabi B.O., Raji H.O., Olarinoye A.O. Abdominal myomectomy: a retrospective review of determinants and outcomes of complications at the University of Ilorin Teaching Hospital, Ilorin, Nigeria. Malawi Med. J. 2017; 29(1): 37-42. https://dx.doi.org/10.4314/mmj.v29i1.8
  10. Dubuisson J., Ramyead L., Streuli I. The role of preventive uterine artery occlusion during laparoscopic myomectomy: a review of the literature. Arch. Gynecol. Obstet. 2015; 291(4): 737-43. https://dx.doi.org/10.1007/s00404-014-3546-4
  11. Санникова М.В., Хабас Г.Н., Макарова А.С., Оводенко Д.Л., Кушлинский Д.Н., Коршунов А.А., Адамян Л.В. Миомэктомия лапароскопическим доступом в условиях временной окклюзии маточных артерий. Акушерство и гинекология. 2016; 1: 68-74. [Sannikova M.V., Khabas G.N., Makarova A.S., Ovodenko D.L., Kushlinsky D.N., Korshunov A.A., Adamyan L.V. Laparoscopic myomectomy for temporary uterine artery occlusion. Obstetrics and Gynecology. 2016; (1): 68-74. (in Russian)]. https://dx.doi.org/10.18565/aig.2016.1.68-74
  12. Макаренко Л.В., Пучков К.В., Крутова В.А., Кулакова Р.А. Возможности современной хирургии в лечении миомы матки у женщин репродуктивного возраста. Современная наука: актуальные проблемы теории и практики. Серия: Естественные и технические науки. 2018; 11: 163-8. [Makarenko L.V., Puchkov K.V., Krutova V.A., Kulakova R.A. Opportunities of modern surgery in the treatment of uterine myoma in women of reproductive age. Modern science: actual problems of theory and practice. Series: Natural and Technical Sciences. 2018; 11: 163-8 (in Russian)].
  13. Попов А.А., Завьялова И.В., Сопова Ю.И., Федоров А.А., Чечнева М.А., Барто Р.А. и др. Актуальные методики снижения кровопотери при реконструктивно-пластических операциях на матке. Российский вестник акушера-гинеколога. 2022; 22(4): 96-102. [Popov A.A., Zav’yalova I.V., Sopova Yu.I., Fedorov A.A., Chechneva M.A., Barto R.A. et al. Current techniques for reducing blood loss during reconstructive uterine surgery. Russian Bulletin of Obstetrician-Gynecologist. 2022; 22(4): 96-102 (in Russian)]. https://dx.doi.org/10.17116/rosakush20222204196
  14. Desai P., Pisat S., Desai Desai S. The "trick" knot - a modified technique of the removable "shoelace" knot for temporary ligation of the uterine artery at its origin. J. Minim. Invasive Gynecol. 2022; 29(12): 1291. https://dx.doi.org/10.1016/j.jmig.2022.09.012
  15. Schnapauff D., Russ M., Kröncke T., David M. Analysis of presurgical uterine artery embolization (PUAE) for very large uterus myomatosus; patient's desire to preserve the uterus; case series and literature review. Rofo. 2018; 190(7): 616-22. https://dx.doi.org/10.1055/s-0044-101555
  16. Akhan S.E., Yasa C., Dural O., Ugurlucan F.G., Rozanes I. Successful pregnancy after presurgical uterine artery embolization in the management of a very large cervical myoma: a case report. Case Rep. Womens Health. 2022; 36: e00450. http://dx.doi.org/10.1016/j.crwh.2022.e00450
  17. Russ M., Hees K.A., Kemmer M., Richter R., Kröncke T., Schnapauff D. et al. Preoperative uterine artery embolization in women undergoing uterus-preserving myomectomy for extensive fibroid disease: a retrospective analysis. Gynecol. Obstet. Invest. 2022; 87(1): 38-45. https://dx.doi.org/10.1159/000521914
  18. McLucas B., Voorhees W.D. 3rd. The effectiveness of combined abdominal myomectomy and uterine artery embolization. Int. J. Gynaecol. Obstet. 2015; 130(3): 241-3. http://dx.doi.org/10.1016/j.ijgo.2015.03.039
  19. Bula Ibula D., Balestra A., Tanos P., Nisolle M., Karampelas S. Uterine artery embolization before myomectomy: is it worth the trouble? J. Minim. Invasive Gynecol. 2025; 32(4): 386-94. http://dx.doi.org/10.1016/j.jmig.2024.11.009
  20. David M., Kröncke T. Preoperative uterine artery embolisation for large uterine fibroids with subsequent uterus preservation - three case histories and review of the literature. Geburtshilfe Frauenheilkd. 2012; 72(6): 539-42. http://dx.doi.org/10.1055/s-0031-1298589
  21. Lunge Patil S., Dave A., Chaudhari K. Prophylactic use of uterine artery embolization to decrease bleeding in laparoscopic myomectomy: a case report. Cureus. 2024; 16(1): e52988. https://dx.doi.org/10.7759/cureus.52988
  22. Hertling S., Schleußner E., Graul L. Validation of uterine artery embolization before surgical laparoscopic myomenucleation compared to single surgical laparoscopic myomenucleation for the treatment of large fibroids and uterus myomatosus. Front. Med. (Lausanne). 2023; 10: 1145952. https://dx.doi.org/10.3389/fmed.2023.1145952
  23. Abrahami Y., Najid S., Petit A., Sauvanet E., Novelli L. Reducing the risk of bleeding after myomectomy: is preemptive embolization a valuable tool? CVIR Endovasc. 2021; 4(1): 42. http://dx.doi.org/10.1186/s42155-021-00231-9
  24. Ludwig P.E., Huff T.J., Shanahan M.M., Stavas J.M. Pregnancy success and outcomes after uterine fibroid embolization: updated review of published literature. Br. J. Radiol. 2020; 93(1105): 20190551. https://dx.doi.org/10.1259/ bjr.20190551
  25. Karlsen K., Hrobjartsson A., Korsholm M., Mogensen O., Humaidan P., Ravn P. Fertility after uterine artery embolization of fibroids: a systematic review. Arch. Gynecol. Obstet. 2018; 297(1): 13-25. https://dx.doi.org/10.1007/s00404-017-4566-7
  26. Арчегова З.У., Касум-заде Н.К., Шалина Р.И. Экстракорпоральное оплодотворение у пациенток после лечения миомы матки различными методами (обзор). Кубанский научный медицинский вестник. 2020; 27(5): 114-27. [Archegova Z.U., Kasum-zade N.K., Shalina R.I. In vitro fertilisation in patients with variant treatment for uterine fibroids (a review). Kuban Scientific Medical Bulletin. 2020; 27(5): 114-27 (in Russian)]. https://dx.doi.org/10.25207/1608-6228-2020-27-5-114-127
  27. Kim C.W., Shim H.S., Jang H., Song Y.G. The effects of uterine artery embolization on ovarian reserve. Eur. J. Obstet. Gynecol. Reprod. Biol. 2016; 206: 172-6. https://dx.doi.org/10.1016/j.ejogrb.2016.09.001
  28. El Shamy T., Amer S.A.K., Mohamed A.A., James C., Jayaprakasan K. The impact of uterine artery embolization on ovarian reserve: a systematic review and meta-analysis. Acta Obstet. Gynecol. Scand. 2020; 99(1): 16-23. https://dx.doi.org/10.1111/aogs.13698
  29. Van der Meulen J.F., Pijnenborg J.M., Boomsma C.M., Verberg M.F., Geomini P.M., Bongers M.Y. Parasitic myoma after laparoscopic morcellation: a systematic review of the literature. BJOG. 2016; 123(1): 69-75. https://dx.doi.org/10.1111/1471-0528.13541
  30. Roberts M.E., Aynardi J.T., Chu C.S. Uterine leiomyosarcoma: a review of the literature and update on management options. Gynecol. Oncol. 2018; 151(3): 562-572. https://dx.doi.org/10.1016/j.ygyno.2018.09.010
  31. Wood L.N., Jamnagerwalla J., Markowitz M.A., Thum D.J., McCarty P., Medendorp A.R. et al. Public awareness of uterine power morcellation through US Food and Drug Administration communications: analysis of Google trends search term patterns. JMIR Public Health Surveill. 2018; 4(2): e47. https://dx.doi.org/10.2196/publichealth.9913
  32. Bogani G., Cliby W.A., Alett G.D. Impact of morcellation on survival outcomes of patients with unexpected uterine leiomyosarcoma: a systematic review and meta-analysis. Gynecol. Oncol. 2015; 137(1): 167-72. https://dx.doi.org/10.1016/j.ygyno.2014.11.011
  33. Wright J.D., Chen L., Burke W.M., Hou J.Y., Tergas A.I., Ananth C.V. et al. Trends in use and outcomes of women undergoing hysterectomy with electric power morcellation. JAMA. 2016; 316(8): 877-8. https://dx.doi.org/10.1001/jama.2016.9432

Received 22.10.2025

Accepted 13.02.2026

About the Authors

Ekaterina A. Loginova, PhD, Researcher at the Laboratory of Gynecology, Department of Pelvic Oncology, Loginov Moscow Clinical Scientific Center, Moscow Healthcare Department, 111123, Russia, Moscow, Novogireevskaya str., 1, +7(495)304-30-35, +7(985)182-28-58, katerina.lg0@gmail.com,
https://orcid.org/0000-0002-5061-1227
Larisa B. Ivanova, PhD, Head of the Laboratory of Gynecology, Department of Pelvic Oncology, Loginov Moscow Clinical Scientific Center, Moscow Healthcare Department, 111123, Russia, Moscow, Novogireevskaya str., 1, +7(495)304-30-35, l.ivanova@mknc.ru
Ramiz K. Valiev, PhD, Head of the Department of Pelvic Oncology, A.S. Loginov Moscow Clinical Scientific Center, Moscow Healthcare Department, 111123, Russia, Moscow, Novogireevskaya str., 1, +7(495)304-30-35, r.valiev@mknc.ru, https://orcid.org/0000-0003-1613-3716
Corresponding author: Ekaterina A. Loginova, katerina.lg0@gmail.com

Similar Articles

№3 / 2024
Levakov S.A., Kaviladze M.G., Guseynova Sh.T.
Uterine fibroids: does the current paradigm of treatment require modernization?
№12 / 2025
Dolgikh M.S., Polenov N.I., Yarmolinskaya M.I., Kogan I.Yu.
Characteristics of blood supply to uterine fibroids after laparoscopic myomectomy in history
№5 / 2024
Dubinskaya E.D., Kolesnikova S.N., Gasparov A.S., Alyoshkina E.V.
Damage-associated molecular patterns in patients with intramural uterine fibroids and infertility
№3 / 2024
Dovletkhanova E.R., Abakarova P.R., Mezhevitinova E.A.
Analogues of gonadotropin-releasing hormone in the treatment of women with uterine fibroids
№3 / 2024
Ponomarenko M.S., Reshetnikov E.A., Ponomarenko I.V., Churnosov M.I.
Risk factors for uterine fibroids
By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.